Xenon Pharmaceuticals Inc (XENE)

Change in Working Capital

$2.43M

Quarterly · Period ending: · USD

XENE logo

XENE Change in Working Capital

Latest reported$2.43M
XENE Quarterly Change in Working Capital ($1.19M → $2.43M)
High-resolution chart · PNG

XENE change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xenon Pharmaceuticals Inc Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
2,431,000
-3,380,000
9,047,283
4,963,000
2,623,000
-12,194,000
2,188,000
-322,000
936,000
-5,949,000
-522,000
-3,298,000
6,892,000
2,563,000
1,066,000
-2,405,000
6,889,000
-6,226,000
1,010,000
-2,567,000
5,894,000
-6,984,000
-2,799,000
-4,292,094
-12,180,295
-7,132,000
29,672,000
953,000
926,000
1,969,000
95,000
-27,000
1,180,000
-1,218,000
365,000
-853,000
304,000
740,000
-46,000
1,905,000
188,000
-279,000
-3,468,000
-4,247,000
-1,301,000
-4,941,000
-4,583,000
-3,305,000
-3,772,000
-2,596,000
-5,343,000
-1,860,000
-506,000
-506,000
1,189,000
1,189,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.